Safety and Immunogenicity of an Inactivated Influenza A/H5N1 Vaccine Given with or without Aluminum Hydroxide to Healthy Adults: Results of a Phase I–II Randomized Clinical Trial
The Journal of Infectious Diseases2008Vol. 198(9), pp. 1309–1316
Citations Over TimeTop 10% of 2008 papers
Wendy A. Keitel, James Campbell, John J. Treanor, Emmanuel B. Walter, Shital M. Patel, Fenhua He, Diana L. Noah, Heather Hill
Abstract
ClinicalTrials.gov identifier: NCT00296634 .
Related Papers
- An overview of scientific and regulatory issues for the immunogenicity of biological products.(2003)
- → Aggregation and Immunogenicity of Therapeutic Proteins(2010)38 cited
- → Immunogenicity of Therapeutic Proteins(2010)29 cited
- [An experimental study of the immunogenicity of Pseudomonas aeruginosa vaccines].(1976)
- → Immunogenicity(2015)